TriangleNCT03511664 · OUTCOME
Time to Improvement After Worsening in BPI-SF Pain Interference Scale
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- Months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- From date of randomization until date of End of Treatment (EoT), assessed up to 32 months (Primary Analysis cut-off date = 27-Jan-2021)
What was measured
Time to improvement after worsening in BPI-SF pain interference scale was defined as the time from worsening of Pain Interference score to a Pain Interference score \<= baseline.
Analysis population: PFS-Full analysis set. Only participants with evaluable events were included in the analysis.
Groups in this outcome
Main Study: 177Lu-PSMA-617 Plus Best Supportive/Best Standard of Care (BS/BSOC)
Patients randomized to receive the investigational product received 7.4 GBq (+/- 10%) 177Lu-PSMA-617 intravenously every 6 weeks (+/- 1 week) for a maximum of 6 cycles. Best supportive/best standard of care (BS/BSOC) might be used
Main Study: Best Supportive/Best Standard of Care (BS/BSOC) Alone
Patients randomized to this arm received best supportive/best standard of care (BS/BSOC) as determined by the investigator
| Group | Source count |
|---|---|
| Main Study: 177Lu-PSMA-617 Plus Best Supportive/Best Standard of Care (BS/BSOC) | 176 |
| Main Study: Best Supportive/Best Standard of Care (BS/BSOC) Alone | 72 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Main Study: 177Lu-PSMA-617 Plus Best Supportive/Best Standard of Care (BS/BSOC) | 3.0 | Not reported | 2.8 | 4.4 | Not reported |
| Main Study: Best Supportive/Best Standard of Care (BS/BSOC) Alone | 2.8 | Not reported | 1.7 | NA | NA: not estimable due the number of censored participants at the time the analysis cut-off date was reached. |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 2.8
- upper Limit
- 4.4
- value
- 3.0
- comment
- NA: not estimable due the number of censored participants at the time the analysis cut-off date was reached.
- group Id
- OG001
- lower Limit
- 1.7
- upper Limit
- NA
- value
- 2.8
- denoms
- counts
- group Id
- OG000
- value
- 176
- group Id
- OG001
- value
- 72
- units
- Participants
- description
- Time to improvement after worsening in BPI-SF pain interference scale was defined as the time from worsening of Pain Interference score to a Pain Interference score \<= baseline.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Patients randomized to receive the investigational product received 7.4 GBq (+/- 10%) 177Lu-PSMA-617 intravenously every 6 weeks (+/- 1 week) for a maximum of 6 cycles. Best supportive/best standard of care (BS/BSOC) might be used
- id
- OG000
- title
- Main Study: 177Lu-PSMA-617 Plus Best Supportive/Best Standard of Care (BS/BSOC)
- description
- Patients randomized to this arm received best supportive/best standard of care (BS/BSOC) as determined by the investigator
- id
- OG001
- title
- Main Study: Best Supportive/Best Standard of Care (BS/BSOC) Alone
- param Type
- MEDIAN
- population Description
- PFS-Full analysis set. Only participants with evaluable events were included in the analysis.
- reporting Status
- POSTED
- time Frame
- From date of randomization until date of End of Treatment (EoT), assessed up to 32 months (Primary Analysis cut-off date = 27-Jan-2021)
- title
- Time to Improvement After Worsening in BPI-SF Pain Interference Scale
- type
- SECONDARY
- unit Of Measure
- Months
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice